Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Johann-Wilhelm Schmier"'
Autor:
Christoph E. Heilig, Bettina Beuthien-Baumann, Johannes Philipzen, Evelin Schröck, Stefan Fröhling, Daniel Hübschmann, Susan Richter, Albrecht Stenzinger, Sebastian Bauer, Hanno Glimm, Veronica Teleanu, Laura Gieldon, Sebastian Uhrig, Peter Horak, Barbara Hutter, Gunhild Mechtersheimer, Daniel B. Lipka, Eva Wardelmann, Christoph Heining, Johann-Wilhelm Schmier, Benedikt Brors, Andreas Mock, Andreas von Deimling, Wolfgang Hartmann, Martina Fröhlich, Simon Kreutzfeldt
Publikováno v:
Genes, Chromosomes and Cancer. 59:601-608
Gastrointestinal stromal tumors (GISTs) are the most frequent mesenchymal tumors of the gastrointestinal tract. Inactivating mutations or epigenetic deregulation of succinate dehydrogenase complex (SDH) genes are considered defining features of a sub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20c1945e655581f9977645a95da9cc59
https://doi.org/10.1002/gcc.22876
https://doi.org/10.1002/gcc.22876
Publikováno v:
Cancer. 123:3167-3175
BACKGROUND When bad news about a cancer diagnosis is being delivered, patient-centered communication (PCC) has been considered important for patients' adjustment and well-being. However, few studies have explored how interpersonal skills might help c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3710dda3b122af7e17db7dfdbfda275a
https://doi.org/10.1002/cncr.30694
https://doi.org/10.1002/cncr.30694
Autor:
Patrick Wuchter, Anthony D. Ho, Gerlinde Egerer, Thomas Schmitt, Florentina Kosely, Johann-Wilhelm Schmier
Publikováno v:
Onkologie. 36(7-8)
Background: Prognosis and survival for patients with metastatic soft tissue sarcoma (STS) are dismal. Standard first-line systemic chemotherapy is anthracycline-based. Gemcitabine/docetaxel (GD) is a therapeutic option in the second-line setting. Her
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f719220770c1dfbeb721ecbf5a80fc4
https://pubmed.ncbi.nlm.nih.gov/23921760
https://pubmed.ncbi.nlm.nih.gov/23921760
Autor:
Georg Hess, Reinhard Marks, Julia Meissner, Mathias Witzens-Harig, Ulrich Keller, Elisabeth Hoenig, Johannes Atta, Anne Crombé, Andreas Viardot, Martin Dreyling, Anthony D. Ho, Christian Buske, Paul LaRosee, Johann Wilhelm Schmier
Publikováno v:
Blood. 128:3028-3028
Purpose. To evaluate the safety, tolerability and efficacy of the combination of the mTOR inhibitor Temsirolimus and a standard salvage regimen (R-DHAP) in patients with relapsed or refractory diffuse large cell B-Cell lymphoma (DLBCL). Methods. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c1488a40e8d9d60ab1a53d52873d518
https://doi.org/10.1182/blood.v128.22.3028.3028
https://doi.org/10.1182/blood.v128.22.3028.3028
Autor:
Patrick Wuchter, Thomas Schmitt, Anthony D. Ho, Sascha Dietrich, Gerlinde Egerer, Johann Wilhelm Schmier
Publikováno v:
Journal of Clinical Oncology. 30:10040-10040
10040 Background: Soft tissue sarcoma (STS) represent a group of rare malignant tumors. Survival for patients with disseminated disease is dismal. Gemcitabine/docetaxel (GD) is a commonly used systemic 2°-line regime in this setting. Methods: Here w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6664afa91cb246e515cfe5d3299c11f
https://doi.org/10.1200/jco.2012.30.15_suppl.10040
https://doi.org/10.1200/jco.2012.30.15_suppl.10040